Kategorier: PR News

Laura Chirica appointed new Board Director in Gradientech

Uppsala, 6 September 2021. The Extra General Meeting at the diagnostic company Gradientech today elected Laura Chirica new Board Director. Laura has 20 years of experience from leading positions within life science, bio process and diagnostic companies, and is currently Chief Commercial Officer at Immunovia AB.

Gradientech’s QuickMIC® showed rapid and reliable results in new study

Gradientech is pleased to announce positive study results obtained from clinical blood culture samples using QuickMIC, Gradientech’s ultra-rapid antibiotic susceptibility testing (AST) system. The antibiotic susceptibility results were available in an average of 3 hours, which is considerably faster than any other phenotypic AST method in the market.

Gradientech Announces Prominent International Scientific Advisory Board

Swedish diagnostics firm Gradientech is proud to announce the appointment of three internationally renowned members to the company’s scientific advisory board, SAB. With their expertise in clinical microbiology, the new advisors will provide valuable support in preparing for a successful market launch of Gradientech’s in vitro diagnostic system for ultra-rapid antibiotic susceptibility testing, claimed to be the fastest among new systems in development.

Gradientech secures $9 million in oversubscribed investment round

Innovative Swedish diagnostics company Gradientech announces closure of an oversubscribed financing round totalling $9 million (SEK 80 million). The round was executed by a combination of existing shareholders and several new investors appointed by Swedish financial advisor, Redeye. Bird & Bird Lawyers acted as legal advisors.


Next-generation antimicrobial susceptibility testing

Take a look at our E-book